How people are using GLP-1s People with type 2 diabetes are using GLP-1 receptor agonists to improve glycemic control, reduce reliance on insulin/other drugs, and reduce risk of diabetes-related complications
Quick Answer Retatrutide has a half-life of approximately 6 days , according to the Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023)
How Storage Practices Affect Research Results Stable storage conditions protect chemical integrity
2020, doi: 10.1038/s41467-020-17556-z
The study examined genetic variants in the GLP1R gene across diverse populations, including 408,774 white British individuals, 50,314 white Europeans, 7,667 South Asians, 10,437 individuals of multiple ancestries, and 7,641 African-Caribbeans
CPT1A iKO, n = 14 mice